Incyte Corporation's ability to collect accounts receivable sequentially worsen to 5.62, pointing to a challenging and on top of that deteriorating business climate for the Medical Laboratories industry. Incyte's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 65 days, from 64 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 337 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 2105 to 2367.

What is Receivable Turnover Ratio?
What is Incyte Corporation Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

INCY Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	27.74 %	20.07 %	18.12 %	14.05 %	10.41 %
Y / Y Revenue Change	20.87 %	27.84 %	20.05 %	16.46 %	19.53 %
Receivable Turnover Ratio (TTM)	5.62	5.73	5.64	5.6	5.56
INCY's Total Ranking	# 2367	# 2105	# 1720	# 2157	# 2108
Accounts Receivable average collection period days	65	64	65	65	66
Seq. Receivable Change	2.64 %	14.35 %	6.29 %	2.4 %	-3.52 %
Seq. Revenue Change	-15.54 %	10.31 %	12.38 %	15.45 %	-10.67 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 17
Healthcare Sector	# 338
Overall Market	# 2367

Receivable Turnover Ratio Statistics
High	Average	Low
18.85	7.85	5.35
(Jun 30 2012)		(Jun 30 2024)

INCY Company Profile • Back to INCY Efficiency Comparisons • Compare INCY Receivables Turnover Ratio to its Competitors

Financial Statements
Incyte's Accounts Receivable	$ 1,051 Millions	Visit INCY's Balance sheet
Incyte's Sales TTM	$ 5,361 Millions	Visit INCY's Income Statement
Sources of INCY's Revenues		Visit INCY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
INCY's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
INCY's Growth Rates	INCY's Roa	INCY's Inventory Turnover Ratio	INCY's Dividend Comparisons
INCY's Profitability Ratios	INCY's Roi	INCY's Asset Turnover Ratio	INCY's Dividend Growth
INCY's Valuation Ratios	INCY's Roe	INCY's Financial Strength Ratios	INCY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Precipio inc	13.93	$ 25.831 Millions	$ 1.854 Millions
Talkspace Inc	13.67	$ 239.269 Millions	$ 17.501 Millions
Amneal Pharmaceuticals Inc	13.56	$ 3,045.530 Millions	$ 224.634 Millions
Skinhealth Systems Inc	13.48	$ 295.223 Millions	$ 21.902 Millions
Lftd Partners Inc	13.33	$ 36.955 Millions	$ 2.773 Millions
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Innoviva Inc	13.13	$ 394.185 Millions	$ 30.016 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Reshape Lifesciences Inc	12.79	$ 2.421 Millions	$ 0.189 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions
Teladoc Health Inc	11.94	$ 2,514.453 Millions	$ 210.660 Millions
Nrc Health	11.77	$ 138.642 Millions	$ 11.777 Millions
Option Care Health Inc	11.65	$ 5,666.577 Millions	$ 486.439 Millions
Crinetics Pharmaceuticals Inc	11.52	$ 18.069 Millions	$ 1.569 Millions
Icu Medical Inc	11.46	$ 2,156.379 Millions	$ 188.157 Millions
Nuvation Bio Inc	11.41	$ 142.121 Millions	$ 12.454 Millions
Vaso Corporation	11.37	$ 88.990 Millions	$ 7.824 Millions
Lifeloc Technologies Inc	11.12	$ 9.044 Millions	$ 0.813 Millions
Cue Biopharma Inc	11.08	$ 32.731 Millions	$ 2.954 Millions
National Healthcare Corp	11.07	$ 1,525.905 Millions	$ 137.813 Millions
Bioaffinity Technologies Inc	10.79	$ 5.660 Millions	$ 0.525 Millions
Vivos Therapeutics Inc	10.73	$ 19.092 Millions	$ 1.779 Millions
Veracyte Inc	10.68	$ 516.183 Millions	$ 48.353 Millions
Immucell Corporation	10.51	$ 29.035 Millions	$ 2.762 Millions

Date modified: 2026-10-05T11:03:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.